Analyst Ratings for 180 Life Sciences
180 Life Sciences Questions & Answers
The latest price target for 180 Life Sciences (NASDAQ: ATNF) was reported by Cantor Fitzgerald on August 12, 2022. The analyst firm set a price target for $4.00 expecting ATNF to rise to within 12 months (a possible 250.88% upside). 100 analyst firms have reported ratings in the last year.
The latest analyst rating for 180 Life Sciences (NASDAQ: ATNF) was provided by Cantor Fitzgerald, and 180 Life Sciences initiated their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of 180 Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for 180 Life Sciences was filed on August 12, 2022 so you should expect the next rating to be made available sometime around August 12, 2023.
While ratings are subjective and will change, the latest 180 Life Sciences (ATNF) rating was a initiated with a price target of $0.00 to $4.00. The current price 180 Life Sciences (ATNF) is trading at is $1.14, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.